The medical device known as a brain scan is the most widely used medical tool in the world, and researchers are developing technology to use it in new ways to treat people with neurological diseases.

A new research paper published in the journal Science describes a prototype device that allows doctors to analyze brain activity while in the scanner.

“The idea is that the brain can be used to make an inference or detect something that might be abnormal in the patient,” said Andrew Hays, a professor of neurobiology and behavioral sciences at the University of Michigan.

“If we can detect something, we can say that the patient’s brain is abnormal.”

Neuroscientists have been using this technology to diagnose neurological conditions such as Alzheimer’s disease, Parkinson’s disease and other conditions that cause cognitive impairment.

Using a brain scanner to detect abnormal activity In this case, Hays said, scientists could detect an abnormality in the brain activity of a person with Alzheimer’s dementia or Parkinson’s.

“It’s very precise.

There are some limitations that you have to take into account,” Hays told The Next Week.

“You can’t do a lot of precise measurements.

It’s a very small part of the body.

But it’s pretty precise.”

Hays and his team developed the prototype brain scanner during a meeting of the American Association for the Advancement of Science.

The team used a specially-designed device, which has a built-in accelerometer, to detect changes in blood flow, which in turn is detected by a magnetometer.

“We can measure the brain’s electrical activity, and we can tell whether it’s normal or abnormal,” Hanes said.

The researchers tested their device on 20 patients, and all of them reported improvement of symptoms.

The patients were able to control their seizures and improve their symptoms without medication, Hanes added.

The device was approved by the FDA for use in the US.

Hays believes the device could be used in a clinical setting in the future.

“When we get the ability to do this, you could have a patient in a clinic where they’re on medication and the brain scan’s helping them with their symptoms,” Hains said.

“But I don’t know if we’ll see it in the clinic.

I think the biggest hurdle is cost.”

The researchers plan to develop a similar device that could be worn on the head or neck, or worn in a bag.

But, Hains noted, that’s a much more expensive process.

“Right now, it’s very difficult to get a device like that to go through the FDA, because the cost is prohibitive,” he said.

However, the researchers are optimistic that their device will soon become a standard tool in clinical use.

“This is the first time that we have the ability and we have to go to the FDA and say that we’ve been working on it and it’s good, so let’s put it on the market,” Hans said.

And the next step is getting approval for the device to be used by patients.

“I think the FDA will approve this and they’ll have the technology to do it, and then it’s a matter of testing,” Hases said.